Neurogene (NGNE) shares slumped 34% pre-bell Tuesday, a day after the company said it will not move forward with its Batten disease gene therapy program.
1847 Holdings (EFSH) shares fell 30%, paring Monday's rally.
General American Investors (GAM) shares were down 18% following a muted session.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments